Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Previous article
Next article
Original Communication

Low-Dose Omega-3 Fatty Acid and Vitamin D for Anthropometric, Biochemical Blood Indices and Respiratory Function. Does it work?

Published Online:April 01, 2019https://doi.org/10.1024/0300-9831/a000476

Abstract

Abstract. Omega-3 fatty acids and vitamin D3 have beneficial effects on different blood, cardiovascular parameters and physical performance. However, the effect of low-dose omega-3 fatty acid supplementation remains unclear. 84 office workers aged 40–60 years, participated in a 16-week open, randomized, placebo-controlled, parallel-group study. The experimental group received 330 mg of omega-3 fatty acid and 0.005 mg (200 IU) of vitamin D3 per day and the control group received placebo. Anthropometric, biochemical blood and respiratory indices were measured at 12 and 16 weeks. Body mass (BM) and body mass index (BMI) significantly reduced in both the experimental (BM from 74.4 ± 13.04 to 73.2 ± 13.02 kg, p < 0.001; BMI from 25.8 ± 4.1 to 25.4 ± 4.3 kg/m2, p < 0.001) and the placebo groups (BM from 69.5 ± 11. to 68.7 ± 11.4 kg, p < 0.05; BMI from 24.1 ± 4.0 to 23.8 ± 4.2 kg/m2, p < 0.05). Omega-3 fatty acid supplementation significantly improved glucose (from 5.12 ± 0.55 to 4.97 ± 0.62 mmol/l; p = 0.05), total cholesterol (from 5.86 ± 1.0 to 5.32 ± 1.55 mmol/l; p = 0.003), and vitamin D levels (from 35.07 ± 21.65 to 68.63 ± 25.94 nmol/l; p = 0.000). Maximal oxygen consumption (from 33.7 ± 2.4 to 36.6 ± 3.2 ml/kg/min, p = 0.035), forced vital capacity (from 3.5 ± 0.6 to 3.9 ± 0.9 l, p = 0.044), forced expiratory volume (from 3.2 ± 0.6 to 3.5 ± 0.7 l, p = 0.014), and peak expiratory flow (from 6.7 ± 1.4 to 7.5 ± 1.6 l/s, p = 0.019) also slightly improved in the omega-3 fatty acid group. Daily supplementation of 330 mg of omega-3 fatty acids had a slight positive impact on total cholesterol and glucose level, while there was no effect on low and high density lipoproteins, and triglycerides levels. Therefore, dose of 330 mg per day seems as insufficient.

References

  • 1 Geleijnse, J.M., Giltay, E.J., Grobbee, D.E., Donders, A.R., & Kok, F.J. (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 20, 1493–1499. First citation in articleCrossref Medline, Google Scholar

  • 2 Skeaff, C.M., & Miller, J. (2009) Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab. 55, 173–201. First citation in articleCrossref Medline, Google Scholar

  • 3 Christensen, J.H., Gustenhoff, P., Korup, E., Aarøe, J., Toft, E., Møller, J.M., Rasmussen, K., Dyerberg, J., & Schmidt, E.B. (1997) n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial. Ugeskr Laeger. 159, 5525–5529. First citation in articleMedline, Google Scholar

  • 4 Ottestad, I., Hassani, S., Borge, G.I., Kohler, A., Vogt, G., Hyötyläinen, T., Orešič, M., Brønner, K.W., Holven, K.B., Ulven, S.M., & Myhrstad, M.C. (2012) Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects. PLoS One. 7(8), e42550. doi: 10.1371/journal.pone.0042550 First citation in articleCrossref Medline, Google Scholar

  • 5 Dangardt, F., Osika, W., Chen, Y., Nilsson, U., Gan, L.M., Gronowitz, E., Strandvik, B., & Friberg, P. (2010) Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents. Atherosclerosis. 212, 580–5. First citation in articleCrossref Medline, Google Scholar

  • 6 Olendzki, B.C., Leung, K., Van Buskirk, S., Reed, G., & Zurier, R.B. (2011) Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids. Evid Based Complement Alternat Med. 2011, 827286. doi: 10.1155/2011/827286 First citation in articleCrossref Medline, Google Scholar

  • 7 Lembke, P., Capodice, J., Hebert, K., & Swenson, T. (2014) Influence of omega-3 (n3) index on performance and wellbeing in young adults after heavy eccentric exercise. J Sports Sci Med. 13, 151–6. First citation in articleMedline, Google Scholar

  • 8 Gopinath, B., Buyken, A.E., Flood, V.M., Empson, M., Rochtchina, E., & Mitchell, P. (2011) Consumption of polyunsaturated fatty acids, fish, and nuts and risk of inflammatory disease mortality. Am J Clin Nutr. 93, 1073–1079. First citation in articleCrossref Medline, Google Scholar

  • 9 Huang, J., Frohlich, J., & Ignaszewski, A.P. (2011) The impact of dietary changes and dietary supplements on lipid profile. Can J Cardiol. 27, 488–505. First citation in articleCrossref Medline, Google Scholar

  • 10 McManus, R.M., Jumpson, J., Finegood, D.T., Clandinin, M.T., & Ryan, E.A. (1996) A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care. 19, 463–7. First citation in articleCrossref Medline, Google Scholar

  • 11 Muldoon, M.F., Erickson, K.I., Goodpaster, B.H., Jakicic, J.M., Conklin, S.M., Sekikawa, A., Yao, J.K., & Manuck, S.B. (2013) Concurrent physical activity modifies the association between n3 long-chain fatty acids and cardiometabolic risk in midlife adults. J Nutr. 143, 1414–20. First citation in articleCrossref Medline, Google Scholar

  • 12 Vega-López, S., Kaul, N., Devaraj, S., Cai, R.Y., German, B., & Jialal, I. (2004) Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism. 53, 236–40. First citation in articleCrossref Medline, Google Scholar

  • 13 Skulas-Ray, A.C., Kris-Etherton, P.M., Harris, W.S., Vanden Heuvel, J.P., Wagner, P.R., & West, S.G. (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr. 93, 243–52. First citation in articleCrossref Medline, Google Scholar

  • 14 Hayati, M.Y., Cawood, A.L., Ding, R., Williams, J.A., Napper, F.L., Shearman, C.P., Grimble, R.F., Payne, S.P., & Calder, P.C. (2013) Limited Impact of 2 g/day Omega-3 Fatty Acid Ethyl Esters (Omacor®) on Plasma Lipids and Inflammatory Markers in Patients Awaiting Carotid Endarterectomy. Mar Drugs. 11, 3569–3581. First citation in articleCrossref Medline, Google Scholar

  • 15 Leslie, M.A., Cohen, D.J.A., Liddle, D.M., Robinson, L.E., & Ma, D.W.L. (2015) A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids Health Dis. 14, 53. doi: 10.1186/s12944-015-0049-7 First citation in articleCrossref Medline, Google Scholar

  • 16 Kris-Etherton, P. M., Harris, W.S., & Appel, L.J. (2002) Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease. Circulation. 106, 2747–2757. First citation in articleCrossref Medline, Google Scholar

  • 17 Bailey, R.L., Gahche, J.J, Miller, P.E., Thomas, P.R., & Dwyer, J.T. (2013) Why US adults use dietary supplements. JAMA Intern Med. 173(5), 355–61. First citation in articleCrossref Medline, Google Scholar

  • 18 Parker, J., Hashmi, O., Dutton, D., Mavrodaris, A., Stranges, S., Kandala, N.B., Clarke, A., & Franco, O.H. (2010) Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 65, 225–36. First citation in articleCrossref Medline, Google Scholar

  • 19 Zittermann, A., Schleithoff, S.S., & Koerfer, R. (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 94(4), 483–492. doi: 10.1079/BJN20051544 First citation in articleCrossref Medline, Google Scholar

  • 20 Jorde, R., & Grimnes, G. (2011) Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 50(4), 303–312. doi: 10.1016/j.plipres.2011.05.001 First citation in articleCrossref Medline, Google Scholar

  • 21 Zittermann, A., Frisch, S., Berthold, H.K., Götting, C., Kuhn, J., Kleesiek, K., Stehle, P., Koertke, H., & Koerfer, R. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 89, 1321–7. First citation in articleCrossref Medline, Google Scholar

  • 22 Kunesova, M., Braunerova, R., Hlavaty, P., Tvrzicka, E., Stankova, B., Skrha, J., Hilgertova, J., Hill, M., Kopecky, J., Wagenknecht, J., Hainer, V., Matoulek, M., Parízkovaa, J., Zak, A., & Svacina, S. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res. 55, 63–72. First citation in articleMedline, Google Scholar

  • 23 Krebs, J.D., Browning, L.M., McLean, N.K., Rothwell, J.L., Mishra, G.D., Moore, C.S., & Jebb, S.A. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond). 30, 1535–1544. First citation in articleCrossref Medline, Google Scholar

  • 24 Thorsdottir, I., Tomasson, H., Gunnarsdottir, I., Gisladottir, E., Kiely, M., Parra, M.D., Bandarra, N.M., Schaafsma, G., & Martinéz, J.A. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond). 31, 1560–1566. First citation in articleCrossref Medline, Google Scholar

  • 25 Crochemore, I.C., Souza, A.F., de Souza, A.C., & Rosado, E.L. (2012) w-3 polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity. Nutr Clin Pract. 27, 553–60. First citation in articleCrossref Medline, Google Scholar

  • 26 Harden, C.J., Dible, V.A., Russell, J.M., Garaiova, I., Plummer, S.F., Barker, M.E., & Corfe, B.M. (2014) Long-chain polyunsaturated fatty acid supplementation had no effect on body weight but reduced energy intake in overweight and obese women. Nutr Res. 34, 17–24. First citation in articleCrossref Medline, Google Scholar

  • 27 Huerta, A.E., Navas-Carretero, S., Prieto-Hontoria, P.L., Martínez, J.A., & Moreno-Aliaga, M.J. (2015) Effects of a-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity (Silver Spring). 23, 313–21. First citation in articleCrossref Medline, Google Scholar

  • 28 Kabir, M., Skurnik, G., Naour, N., Pechtner, V., Meugnier, E., Rome, S., Quignard-Boulange, A., Vidal, H., Slama, G., Clement, K., Guerre-Millo, M., & Rizkalla, S.W. (2007) Treatment for 2 mo with n_3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in First citation in articleGoogle Scholar

  • 29 Hill, A.M., Buckley, J.D., Murphy, K.J., & How, P. (2007) Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr. 85, 1267–74. First citation in articleCrossref Medline, Google Scholar

  • 30 Noreen, E.E., Sass, M.J., Crowe, M.L., Pabon, V.A., Brandauer, J., & Averill, L.K. (2010) Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults. J Int Soc Sports Nutr. 7, 31. doi: 10.1186/1550-2783-7-31 First citation in articleCrossref Medline, Google Scholar

  • 31 Munro, I.A., & Garg, M.L. (2012) Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr. 108, 1466–74. First citation in articleCrossref Medline, Google Scholar

  • 32 Brinson, B.E., & Miller, S. (2012) Fish Oil What is the Role in Cardiovascular Health? J Pharm Pract. 25, 69–74. First citation in articleCrossref Medline, Google Scholar

  • 33 Eslick, G.D., Howe, P.R., Smith, C., Priest, R., & Bensoussan, A. (2009) Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 136, 4–16. First citation in articleCrossref Medline, Google Scholar

  • 34 Poppitt, S.D., Howe, C.A., Lithander, F.E., Silvers, K.M., Lin, R.B., Croft, J., Ratnasabapathy, Y., Gibson, R.A., & Anderson, C.S. (2009) Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: a randomized, controlledtrial. Stroke. 40, 3485–92. First citation in articleCrossref Medline, Google Scholar

  • 35 Woodman, R.J., Mori, T.A., Burke, V., Puddey, I.B., Watts, G.F., & Beilin, L.J. (2002) Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 76, 1007–15. First citation in articleCrossref Medline, Google Scholar

  • 36 Cazzola, R., Russo-Volpe, S., Miles, E.A., Rees, D., Banerjee, T., Roynette, C.E., Wells, S.J., Goua, M., Wahle, K.W., Calder, P.C., & Cestaro, B. (2007) Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects. Atherosclerosis. 193, 159–67. First citation in articleCrossref Medline, Google Scholar

  • 37 Egert, S., Kannenberg, F., Somoza, V., Erbersdobler, H.F., & Wahrburg, U. (2009) Dietary a-Linolenic Acid, EPA, and DHA Have Differential Effects on LDL Fatty Acid Composition but Similar Effects on Serum Lipid Profiles in Normolipidemic Humans. J Nutr. 139, 861–868. First citation in articleCrossref Medline, Google Scholar

  • 38 Thusgaard, M., Christensen, J.H., Mørn, B., Andersen, T.S., Vige, R., Arildsen, H., Schmidt, E.B., & Nielsen, H. (2009) Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Scand J Infect Dis. 41, 760–6. First citation in articleCrossref Medline, Google Scholar

  • 39 Damsgaard, C.T., Frøkiær, H., Andersen, A.D., & Lauritzen, L. (2008) Fish Oil in Combination with High or Low Intakes of Linoleic Acid Lowers PlasmaTriacylglycerols but Does Not Affect Other Cardiovascular Risk Markers in Healthy Men. J Nutr. 138, 1061–1066. First citation in articleCrossref Medline, Google Scholar

  • 40 Shidfar, F., Keshavarz, A., Hosseyni, S., Ameri, A., & Yarahmadi, S. (2008) Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients. East Mediterr Health J. 14, 305–13. First citation in articleMedline, Google Scholar

  • 41 Mostad, I.L., Bjerve, K.S., Bjorgaas, M.R., Lydersen, S., & Grill, V. (2006) Effects of n_3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr. 84, 540–50. First citation in articleCrossref Medline, Google Scholar

  • 42 International Society for the Study of Fatty Acids and Lipid. (2004) Report of the sub-committee on recommendations for intake of polyunsaturated fatty acids in healthy adults. Available at: http://www.issfal.org/newslinks/resources/publications/PUFAIntakeReccomdFinalReport.pdf First citation in articleGoogle Scholar

  • 43 Bresson, J.L., Flynn, A., Heinonen, M., Hulshof, K., Korhonen, H., Lagiou, P., et al. (2009) European Food Safety Authority. Scientific Opinion: Labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids. The EFSA Journal. 1176, 1–11. First citation in articleGoogle Scholar

  • 44 Ono, Y., Suzuki, A., Kotake, M., Zhang, X., Nishiwaki-Yasuda, K., Ishiwata, Y., et al. (2005) Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in a normal Japanese population. Bone Miner Metab. 23, 147–151. doi: 10.1007/s00774-004-0553-8 First citation in articleCrossref Medline, Google Scholar

  • 45 Rockell, J.E., Skeaff, C.M., Williams, S.M., & Green, T.J. (2006) Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int. 17(9), 1382–9. First citation in articleCrossref Medline, Google Scholar

  • 46 Bolland, M.J., Grey, A.B., Ames, R.W., Mason, B.H., Horne, A.M., Gamble, G.D., & Reid, R. (2007) The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency1_3. Am J Clin Nutr. 86, 959–64. First citation in articleCrossref Medline, Google Scholar

  • 47 Hypponen, E., & Power, C. (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 85(3), 860–8. First citation in articleCrossref Medline, Google Scholar

  • 48 Hill, T.R., Cotter, A.A., Mitchell, S., Boreham, C.A., Dubitzky, W., Murray, L., Strain, J.J., Flynn, A., Robson, P.J., Wallace, J.M., Kiely, M., & Cashman, K.D. (2008) Vitamin D status and its determinants in adolescents from the Northern Ireland Young Hearts 2000 cohort. Br J Nutr. 99(5), 1061–7. doi: 10.1017/S0007114507842826 First citation in articleCrossref Medline, Google Scholar

  • 49 Kull, M., Kallikorm, R., Tamm, A., & Lember, M. (2009) Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country. BMC Public Health. 9, 22. doi: 10.1186/1471-2458-9-22 First citation in articleCrossref Medline, Google Scholar

  • 50 Andersen, R., Brot, C., Jakobsen, J., Mejborn, H., Mølgaard, C., Skovgaard, L.T., Trolle, E., Tetens, I., & Ovesen, L. (2013) Seasonal changes in vitamin D status among Danish adolescent girls and elderly women: the influence of sun exposure and vitamin D intake. European Journal of Clinical Nutrition. 67, 270–274. First citation in articleCrossref Medline, Google Scholar

  • 51 Gupta, A.K., Brashear, M.M., & Johnson, W.D. (2011) Prediabetes and Prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care. 34(3), 658–660. First citation in articleCrossref Medline, Google Scholar

  • 52 Pittas, A.G., Sun, Q., Manson, J.E., & Dawson-Hughes, B. (2010) Hu FB Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 33(9), 2021–2023. First citation in articleCrossref Medline, Google Scholar

  • 53 Robinson, J.G., Manson, J.E., Larson, J., Liu, S., Song, Y., Howard, B.V., et al. (2011) Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care. 34(3), 628–634. First citation in articleCrossref Medline, Google Scholar

  • 54 Wang, H., Xia, N., Yang, Y., & Peng, D. (2012) Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 11, 42. First citation in articleCrossref Medline, Google Scholar

  • 55 Haghravan, S., Keshavarz, S.A., Mazaheri, R., Alizadeh, Z., & Mansournia, M.A. (2016) Effect of Omega-3 PUFAs Supplementation with Lifestyle Modification on Anthropometric Indices and Vo2 max in Overweight Women. Arch Iran Med. 19, 342–7. First citation in articleMedline, Google Scholar

  • 56 Brilla, L.R., & Landerholm, T.E. (1990) Effect of fish oil supplementation and exercise on serum lipids and aerobic fitness. J Sports Med Phys Fitness. 30(2), 173–80. First citation in articleMedline, Google Scholar

  • 57 Macaluso, F., Barone, R., Catanese, P., Carini, F, Rizzuto, L., Farina, F., & Di Felice, V. (2013) Do fat supplements increase physical performance? Nutrients. 5, 509–524. First citation in articleCrossref Medline, Google Scholar

  • 58 Huffman, D.M., Altena, T.S., Mawhinney, T.P., & Thomas, T.R. (2004) Effect of n-3 fatty acids on free tryptophan and exercise fatigue. European Journal of Applied Physiology. 92, 584–591. First citation in articleCrossref Medline, Google Scholar

  • 59 Buckley, J.D., Burgess, S., Murphy, K.J., & Howe, P.R. (2009) DHA-rich fish oil lowers heart rate during submaximal exercise in elite Australian Rules footballers. Journal of Science and Medicine in Sport. 12, 503–507. First citation in articleCrossref Medline, Google Scholar

  • 60 Peoples, G.E., McLennan, P.L., Howe, P.R., & Groeller, H. (2008) Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol. 52, 540–547. First citation in articleCrossref Medline, Google Scholar

  • 61 Tiryaki-Sönmez, G., Schoenfeld, B., & Vatansever-Ozen, S. (2011) Omega-3 fatty acids and exercise: a review of their combined effects on body composition and physical performance. Biomedical Human Kinetics. 3, 23–29. doi: 10.2478/v10101-011-0007-4 First citation in articleCrossref, Google Scholar

  • 62 Bays, H.E., Maki, K.C., Doyle, R.T., & Stein, E. (2009) The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels. Postgrad Med. 121, 145–50. First citation in articleCrossref Medline, Google Scholar

  • 63 DeFina, L.F., Marcoux, L.G., Devers, S.M., Cleaver, J.P., & Willis, B.L. (2011) Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr. 93, 455–62. First citation in articleCrossref Medline, Google Scholar

  • 64 Borkman, M., Chisholm, D.J., Furler, SM., Storlien, L.H., Kraegen, E.W., Simons, L.A., & Chesterman, C.N. (1989) Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes. 38, 1314–9. First citation in articleCrossref Medline, Google Scholar

  • 65 Ciubotaru, I., Lee, Y.S., & Wander, R.C. (2003) Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem. 14, 513–21. First citation in articleCrossref Medline, Google Scholar

  • 66 Dawczynski, C., Martin, L., Wagner, A., & Jahreis, G. (2010) n-3 LC-PUFA-enriched dairy products are able to reduce cardiovascular risk factors: a double-blind, cross-over study. Clin Nutr. 29, 592–9. First citation in articleCrossref Medline, Google Scholar

  • 67 Fakhrzadeh, H., Ghaderpanahi, M., Sharifi, F., Mirarefin, M., Badamchizade, Z., Kamrani, A.A., & Larijani, B. (2010) The effects of low dose n-3 fatty acids on serum lipid profiles and insulin resistance of the elderly: a randomized controlled clinical trial. Int J Vitam Nutr Res. 80, 107–16. First citation in articleLink, Google Scholar

  • 68 Dewell, A., Marvasti, F.F., Harris, W.S., Tsao, P., & Gardner, C.D. (2011) Low- and High-Dose Plant and Marine (n-3) Fatty Acids Do Not Affect Plasma Inflammatory Markers in Adults with Metabolic Syndrome. J Nutr. 141, 2166–2171. First citation in articleCrossref Medline, Google Scholar

  • 69 Maki, K.C., Lawless, A.L., Kelley, K.M., Dicklin, M.R., Kaden, V.N., Schild, A.L., Rains, T.M., & Marshall, J.W. (2011) Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia. J Cardiovasc Pharmacol. 57, 489–94. First citation in articleCrossref Medline, Google Scholar

  • 70 Vargas, M.L., Almario, R.U., Buchan, W., Kim, K., & Karakas, S.E. (2011) Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism. 60, 1711–8. First citation in articleCrossref Medline, Google Scholar

  • 71 Schirmer, S.H., Werner, C.M., Binder, S.B., Faas, M.E., Custodis, F., Böhm, M., & Laufs, U. (2012) Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation. Atherosclerosis. 225, 166–72. First citation in articleCrossref Medline, Google Scholar

  • 72 Oelrich, B., Dewell, A., & Gardner, C.D. (2013) Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults. Nutr Metab Cardiovasc Dis. 23, 350–7. First citation in articleCrossref Medline, Google Scholar